Piekos Brian 4
4 · Elicio Therapeutics, Inc. · Filed Jun 5, 2023
Insider Transaction Report
Form 4
Piekos Brian
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-06-01+75,484→ 75,484 totalExercise: $10.00Exp: 2033-06-01→ Common Stock (75,484 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on May 15, 2024 with the remainder vesting in 36 equal monthly installments at the end of each month thereafter, subject to the Reporting Person continuing to provide services to the Issuer through the applicable vesting dates, and provided that in the event there is a change in control of the Issuer, followed by a subsequent termination of the Reporting Person's employment without cause (or a material diminishment of his role) within 12 months of the change of control, any unvested options granted will immediately vest.